Latest news

19 Jul 2019 News
Biosensor created to rapidly detect cancer cells after chemotherapy
17 Jul 2019 News
Zejula® significantly improves progression-free survival in ovarian cancer patients
12 Jul 2019 Breast
Palbociclib and crizotinib combination could overcome tumor treatment resistance
9 Jul 2019 Colorectal
Triple drug combination improves survival in advanced bowel cancer patients

Video

View all videos

17 Jul 2019 Clinical trials
Accelerating biomarker-guided drug development with Precision For Medicine

Video

View all videos

Features

Stay up to date

Upcoming event

ESMO Breast Cancer 2019 – annual congress

May 2, 2019 – May 4, 2019

Berlin, Germany

View all

Upcoming event

American Society of Clinical Oncology (ASCO) annual meeting

May 31, 2019 – June 4, 2019

IL, USA

View all

Tweets

Oncology Central @OncologyCentral·

Study findings suggest that targeted drugs for #breastcancer and #lungcancer could be used in combination to overcome treatment resistance in several tumor types. Click the image below for the full news story: https://t.co/G0ehbbdLpN

View all

Jobs

Connecting talent with opportunity. View our featured jobs

View all

Our mission statement

At Oncology Central we are dedicated to advancing oncology by publishing trusted, engaging and insightful resources for the global oncology community.

Learn more

Biosensor created to rapidly detect cancer cells after chemotherapy

Zejula® significantly improves progression-free survival in ovarian cancer patients

Palbociclib and crizotinib combination could overcome tumor treatment resistance

Triple drug combination improves survival in advanced bowel cancer patients

Spotlight survey on organoids on oncology

Pembrolizumab for small-cell lung cancer: an interview with Hyun Cheol Chung

Pharma, President, Patients: the cancer cost conundrum

Enhancing and improving CAR-T cell therapy: an interview with Bruce Levine

I-O Optimise: a multinational program providing real-world insights into lung cancer management

Scientific survival suggestions: V. Craig Jordan’s top 10 tips

Unlocking the power of the cancer genome: an interview with Phil Febbo, Illumina Inc.

Colorectal cancer screening age to be lowered to 50 in England

Exploring the Thyroid Imaging Reporting and Data System (TI-RADS): an interview with Franklin Tessler

Video

Accelerating biomarker-guided drug development with Precision For Medicine

Video

Login

Latest news

Biosensor created to rapidly detect cancer cells after chemotherapy

Zejula® significantly improves progression-free survival in ovarian cancer patients

Palbociclib and crizotinib combination could overcome tumor treatment resistance

Triple drug combination improves survival in advanced bowel cancer patients

Featured articles

Spotlight survey on organoids on oncology

Pembrolizumab for small-cell lung cancer: an interview with Hyun Cheol Chung

Pharma, President, Patients: the cancer cost conundrum

Enhancing and improving CAR-T cell therapy: an interview with Bruce Levine

I-O Optimise: a multinational program providing real-world insights into lung cancer management

Scientific survival suggestions: V. Craig Jordan’s top 10 tips

Unlocking the power of the cancer genome: an interview with Phil Febbo, Illumina Inc.

Colorectal cancer screening age to be lowered to 50 in England

Exploring the Thyroid Imaging Reporting and Data System (TI-RADS): an interview with Franklin Tessler

Video

Accelerating biomarker-guided drug development with Precision For Medicine

Video

Improving clinical trial success with Carla Balch

Addressing unmet needs in pancreatic cancer with Pascal Hammel

Addressing unmet needs in pancreatic cancer with Pascal Hammel

Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

Emerging treatment options for pancreatic cancer with Thomas Seufferlein

Tamoxifen, SERMs and sustainable medicine

Features

Interviews

Spotlights

Journal articles

Stay up to date

Oncology Central Newsletter